Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Innova Memphis
AddedFeb 15, 2024
UpdatedJul 16, 2026
Innova Memphis

Innova Memphis

Operating

Innova: Investing in biosciences, technology, and AgTech startups since 2007, linking capital with innovation for market success.

Location
Memphis, TN, US
Founded
2007
Firm
Compare
Portfolio
Employees
Website

Investments

Rantizo
Rantizo

Total Raised

$14.5M

Rounds

6

Series A$6MOctober 2023
Convertible NoteMay 2022
Birds Eye Robotics
Birds Eye Robotics

Total Raised

$3.6M

Rounds

6

Seed$750kMarch 2023
Pre-SeedJuly 2021
Beta Hatch
Beta Hatch

Total Raised

$42M

Rounds

8

Convertible NoteDecember 2022
Series Unknown$10MAugust 2021
Stony Creek Colors
Stony Creek Colors

Total Raised

$20.6M

Rounds

11

Series B$4.8MDecember 2022
Convertible NoteSeptember 2022
Convertible NoteMarch 2022
Series B$9MMarch 2021
Phinite
Phinite

Total Raised

$2.7M

Rounds

5

Seed$1MOctober 2022
Tractor Zoom
Tractor Zoom

Total Raised

$11.3M

Rounds

5

Series A$5MOctober 2022
Glanris
Glanris

Total Raised

$7.4M

Rounds

8

Series Unknown$1.8MAugust 2022
Convertible NoteJune 2022
Convertible NoteJanuary 2022
Series A$2MMarch 2021
HerdDogg
HerdDogg

Total Raised

$13.5M

Rounds

8

—May 2022
Convertible Note$1.4MNovember 2021
Innatrix
Innatrix

Total Raised

$573.1k

Rounds

6

Pre-SeedJanuary 2022
Ag Manufacturing & Technology
Ag Manufacturing & Technology

Total Raised

$1.6M

Rounds

3

Convertible NoteDecember 2021
Clean Crop Technologies
Clean Crop Technologies

Total Raised

$11.4M

Rounds

4

Series A$6MDecember 2021
Grain Weevil
Grain Weevil

Total Raised

$1.8M

Rounds

3

Seed$1.5MNovember 2021
Shurpa
Shurpa

Total Raised

$1.7M

Rounds

5

SeedNovember 2021
Path EX
Path EX

Total Raised

$4.8M

Rounds

10

Convertible Note$2.5MJune 2021
BioNova
BioNova

Total Raised

$2.9M

Rounds

5

Series A$1MMay 2021